UK markets closed

  • FTSE 100

    6,695.07
    -20.35 (-0.30%)
     

  • FTSE 250

    20,596.91
    -196.81 (-0.95%)
     

  • AIM

    1,195.31
    -2.78 (-0.23%)
     

  • GBP/EUR

    1.1236
    -0.0045 (-0.40%)
     

  • GBP/USD

    1.3685
    -0.0046 (-0.33%)
     

  • BTC-GBP

    23,239.29
    +0.54 (+0.00%)
     

  • CMC Crypto 200

    651.44
    +41.45 (+6.79%)
     

  • S&P 500

    3,841.47
    -11.60 (-0.30%)
     

  • DOW

    30,996.98
    -179.03 (-0.57%)
     

  • CRUDE OIL

    51.98
    -1.15 (-2.16%)
     

  • GOLD FUTURES

    1,855.50
    -10.40 (-0.56%)
     

  • NIKKEI 225

    28,631.45
    -125.41 (-0.44%)
     

  • HANG SENG

    29,447.85
    -479.91 (-1.60%)
     

  • DAX

    13,873.97
    -32.70 (-0.24%)
     

  • CAC 40

    5,559.57
    -31.22 (-0.56%)
     
Week ahead:

Digital Davos, UK jobs data, US GDP and Biden's first week

Joe Biden’s new team will get the lay of the land with fourth quarter GDP data

DNA’s financial information and Annual General Meeting in 2021

DNA Oyj
·1-min read

DNA PLC STOCK EXCHANGE RELEASE 17 December 2020, 10:00 am EET

In 2021, DNA will publish its financial statements, semi-annual report and business reviews sent as press releases as follows:

  • 2 February 2021: Financial statements bulletin for 2020

  • 4 May 2021: January-March 2021 business review as press release

  • 20 July 2021: Half year (January-June) 2021 financial report

  • 28 October 2021: January-September 2021 business review as press release

DNA’s electronic annual report, which contains the complete Financial Statements 2020, will be published at the latest during the week starting from 1 March 2021 (week 9/2021).

DNA's Annual General Meeting is planned to be held on 26 March 2021.

Further information:
Timo Karppinen, CFO, DNA Plc, tel. +358 (0)44 044 5007, timo.karppinen@dna.fi
DNA Corporate Communications, tel. +358 44 044 8000, communications@dna.fi


Latest stories